Factsheet
As of 20 Dec 2024
JSP
-
Consumer Products
/
-
CG Report :
-
SET ESG Ratings :
-
Business Type
Develop, manufacture, and sell modern medicine, traditional medicine, herbal product, dietary supplement, medical supply, and cleaning alcohol under client's trademark and the Company's trademark.
237.29
949.15
1,444.71
111.42
10.69
2.00
3.02 /
1.88
18.63
1.06
Company Profile
255,257, Soi Sathupradit 58, Bangpongpang Sub-district, Yannawa District Bangkok 10120
0-2284-1218
0-2294-0705
FINNEX ADVISORY COMPANY LIMITED
SIAM ALPHA CAPITAL COMPANY LIMITED
02 Nov 2021
7.00 @Par Value
0.50
Baht
0.50
Baht
Old -
: New - @
-
Shareholders
As of -
3,489 (as of 14 Mar 2024)
32.64% (as of 14 Mar 2024)
0.02% (as of 20 Dec 2024)
49.00% (as of 20 Dec 2024)
3,877 (as of 15 Mar 2023)
26.37% (as of 15 Mar 2023)
0.24% (as of 20 Dec 2024)
Board of Directors / Management
5 Yr Price Performance (Adjusted Price)
Change
Price Performance (Adjusted Price)
Statistics
Accumulated: Turnover Ratio, Value Trade/Day
Rate of Return
Dividend
Latest News
Auditor (Effective Until 31 Dec 2024)
Ms. SUKANYA RODKROH (KPMG PHOOMCHAI AUDIT LIMITED)Ms. NADSASIN WATTANAPAISAL (KPMG PHOOMCHAI AUDIT LIMITED)Miss KANOKON PHOORIPHANYAWANIT (KPMG PHOOMCHAI AUDIT LIMITED)
Unqualified opinion with an emphasis of matters
31 ธ.ค.
Financial Statements Submission Information
Financial Data
Statement of Financial Position Unit: M.Baht
Statement of Comprehensive Income Unit: M.Baht
Statement of Cash Flow Unit: M.Baht
Ratios Annualized : ROE,
ROA
Growth Rate (%)
Cash Cycle Annualized
Capital Movement (Last 3 Year)
Information only PP, PO, XR and XD
Trading Sign (Latest)
- Calculated from adjusted price
- Presented and calculated from the consolidated statement and displayed as cumulative quarterly statement by fiscal year (Company statement will be presented and calculated incase consolidated statement is not available.)
- The information is quarterly updated within 7 business days after the new financial statement is submitted
- Information on the financial statements is presented according to the information that the listed companies submit on that period. The investors should study additional information from the companies' financial statements since some companies may restate the comparing financial statements on the latest financial statements.